Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Financial Statements
Shandong Xinhua Pharmaceutical Company Limited Class H Financial Overview
Shandong Xinhua Pharmaceutical Company Limited Class H's market cap is currently $941.24M. The company's EPS TTM is $0.33; its P/E ratio is 37.23; and it has a dividend yield of 3.18%. Shandong Xinhua Pharmaceutical Company Limited Class H is estimated to report earnings on March 31, 2027, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.75B | $ 8.47B | $ 8.10B | $ 7.50B | $ 6.56B |
| Gross Profit | $ 1.64B | $ 2.04B | $ 2.32B | $ 2.04B | $ 1.77B |
| Operating Income | $ 363.98M | $ 534.37M | $ 534.58M | $ 476.71M | $ 425.59M |
| EBITDA | $ 988.87M | $ 1.11B | $ 1.09B | $ 1.01B | $ 908.67M |
| Net Income | $ 289.89M | $ 470.02M | $ 496.51M | $ 411.06M | $ 348.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.40B | $ 1.25B | $ 918.33M | $ 1.16B | $ 744.66M |
| Total Assets | $ 9.19B | $ 9.02B | $ 8.29B | $ 8.27B | $ 7.33B |
| Total Debt | $ 1.31B | $ 1.35B | $ 1.08B | $ 1.38B | $ 1.04B |
| Net Debt | $ -84.19M | $ 107.78M | $ 166.60M | $ 225.11M | $ 299.09M |
| Total Liabilities | $ 3.73B | $ 3.80B | $ 3.51B | $ 3.92B | $ 3.68B |
| Stockholders' Equity | $ 5.21B | $ 4.99B | $ 4.55B | $ 4.13B | $ 3.47B |
| Cash Flow | |||||
| Free Cash Flow | $ 418.13M | $ 155.19M | $ -59.85M | $ 513.48M | $ 9.89M |
| Operating Cash Flow | $ 533.73M | $ 367.61M | $ 265.28M | $ 758.24M | $ 259.12M |
| Investing Cash Flow | $ -103.50M | $ -212.21M | $ -305.11M | $ -228.90M | $ -237.69M |
| Financing Cash Flow | $ -291.13M | $ 184.78M | $ -196.11M | $ -130.66M | $ -139.73M |
Currency in CNY